Search results

Order by most recent / most popular / relevance

Results: 1-10 of 26

Israeli biotechnology startups seek partnerships in Ohio

Shook Hardy & Bacon LLP
-
USA
-
December 16 2010

Israeli biotechnology companies are reportedly heading to Ohio because of state incentives and a venture capital fund focused on investing in Israel

Mergers affect Boston biotech independence

Shook Hardy & Bacon LLP
-
USA
-
April 21 2011

Biotech company executives meeting recently in Boston, were reportedly concerned about the growing buy-out trend among area businesses

Joint venture to create algae for biofuels

Shook Hardy & Bacon LLP
-
USA
-
April 21 2011

Bard Holding Inc. and Algae Bioenergy Solutions (ABS) have announced a joint venture to develop an algae production facility in Augusta, Georgia

Chinese billionaire backs U.S.China biopharma venture

Shook Hardy & Bacon LLP
-
China, USA
-
April 21 2011

Chinese real-estate billionaire Qi Jinzing has reportedly begun investing in the biotech sector despite its potential financial risks

Pharma merger activity attributed to “patent cliff”

Shook Hardy & Bacon LLP
-
USA
-
November 18 2010

Noting that many of the pharmaceutical industry's best-selling products will soon lose their patent protection, industry analysts have reportedly suggested that the potential loss of nearly one-third of industry revenues in the near term could account for recent merger activity among the world's largest pharmaceutical companies

Fewer small biotech companies go public

Shook Hardy & Bacon LLP
-
USA
-
March 10 2011

Smaller biotechnology companies maneuvering through drug-development regulations are reportedly focusing their efforts on licensing products in development or selling their businesses to large pharmaceutical companies rather than pursuing an initial public offering (IPO

Agilent Technologies acquires BIOCIUS Life Sciences

Shook Hardy & Bacon LLP
-
USA
-
March 10 2011

California-based Agilent Technologies has announced the acquisition of BIOCIUS Life Sciences, a Massachusetts-based company that developed a spectrometry device, enabling "researchers to gain a fuller understanding of a drug's biochemical properties, including potential liabilities in drug interactions

Medicinova and Zhejiang Medicine announce joint venture in China

Shook Hardy & Bacon LLP
-
China, USA
-
March 10 2011

California-based biopharmaceutical company MediciNova Inc. and Zhejiang Medicine Co., a Chinese pharmaceutical manufacturer, have announced a joint venture to develop and commercialize MediciNova’s MN-221 in China

Osage University Partners affiliates with top universities

Shook Hardy & Bacon LLP
-
USA
-
March 10 2011

Pennsylvania-based Osage University Partners has announced the successful closing of its $100-million debut venture fund, which was created to partner with leading research universities "to license cutting-edge technologies," particularly in therapeutics

Berg, GNS announce joint venture to enhance therapeutic & diagnostic development

Shook Hardy & Bacon LLP
-
USA
-
March 10 2011

Massachusetts-based Berg Biosystems, LLC and GNS Healthcare, Inc. have announced a joint venture “to accelerate advancements in critical biomedical research” and reposition “existing drugs for use in new indications with collaborators.”